Terms: = Breast cancer AND MNX1, HB9, 3110, ENSG00000130675, P50219, HLXB9
19 results:
1. mnx1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive breast cancer.
Chi W; Xiu B; Xiong M; Wang X; Li P; Zhang Q; Hou J; Sang Y; Zhou X; Chen M; Zheng S; Zhang L; Xue J; Chi Y; Wu J
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203393
[TBL] [Abstract] [Full Text] [Related]
2. Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study.
Di Maio M; Bighin C; Schettini F; Ruelle T; Marandino L; Fabi A; De Angelis C; Giuliano M; De Placido P; De Laurentiis M; Riccardi F; Picotto C; Puglisi F; Del Mastro L; Arpino G;
Breast; 2023 Dec; 72():103583. PubMed ID: 37783133
[TBL] [Abstract] [Full Text] [Related]
3. Impact of procedure type on revisional surgery and secondary reconstruction after immediate breast reconstruction in a population-based cohort.
Johnson L; White P; Holcombe C; O'Donoghue J; Jeevan R; Browne J; Fairbrother P; MacKenzie M; Gulliver-Clarke C; Mohiuddin S; Hollingworth W; Potter S
Br J Surg; 2023 May; 110(6):666-675. PubMed ID: 36998148
[TBL] [Abstract] [Full Text] [Related]
4. Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma.
Rebbeck CA; Xian J; Bornelöv S; Geradts J; Hobeika A; Geiger H; Alvarez JF; Rozhkova E; Nicholls A; Robine N; Lyerly HK; Hannon GJ
Nat Commun; 2022 Jun; 13(1):3399. PubMed ID: 35697697
[TBL] [Abstract] [Full Text] [Related]
5. Surgeon Assessment of the Technical Impact of Neoadjuvant Systemic Therapy on Operable Stage III Melanoma.
Hieken TJ; Price DL; Piltin MA; Turner HJ; Block MS
Ann Surg Oncol; 2022 Feb; 29(2):780-786. PubMed ID: 34825282
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic and therapeutic ERβ, HER2, BRCA biomakers in the histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification.
Zhong L; Zhang C; Jia W; Zhang P
Ann Diagn Pathol; 2021 Apr; 51():151700. PubMed ID: 33465722
[TBL] [Abstract] [Full Text] [Related]
7. Clinical significance of HER2 status in T1bN0 breast cancer: a nationwide study from the Korean breast cancer Society.
Kang YJ; Oh SJ; Choi H; Cho S; Shin CH; Kim C; Woo J; Lee J; Park HK; Lee HB; Noh WC; Kim YS
Breast Cancer Res Treat; 2021 Feb; 186(1):125-134. PubMed ID: 33389401
[TBL] [Abstract] [Full Text] [Related]
8. [Values of Minimal Apparent Diffusion Coefficient,Difference between Ratios of Apparent Diffusion Coefficients,and Dynamic Contrast-enhanced Magnetic Resonance Imaging Features in Diagnosing breast Ductal Carcinoma In Situ with Microinvasion].
Wu P; Cui L; Guo BH; Wang YC; Cui JS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):737-745. PubMed ID: 31907122
[No Abstract] [Full Text] [Related]
9. Characterization of breast lesions using diffusion kurtosis model-based imaging: An initial experience.
Zhou WP; Zan XY; Hu XY; Liu X; Sudarshan SKP; Yang SD; Guo YJ; Fang XM
J Xray Sci Technol; 2020; 28(1):157-169. PubMed ID: 31815728
[TBL] [Abstract] [Full Text] [Related]
10. Application of the optimized and validated LC-MS method for simultaneous quantification of tryptophan metabolites in culture medium from cancer cells.
Sadok I; Rachwał K; Staniszewska M
J Pharm Biomed Anal; 2019 Nov; 176():112805. PubMed ID: 31415991
[TBL] [Abstract] [Full Text] [Related]
11. Long non-coding RNA mnx1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
Ji D; Wang Y; Sun B; Yang J; Luo X
Biochem Biophys Res Commun; 2019 Jun; 513(3):669-674. PubMed ID: 30982576
[TBL] [Abstract] [Full Text] [Related]
12. Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China.
Tang LC; Jin X; Yang HY; He M; Chang H; Shao ZM; Di GH
BMC Cancer; 2015 Mar; 15():201. PubMed ID: 25885213
[TBL] [Abstract] [Full Text] [Related]
13. Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts.
Ek WE; Reznichenko A; Ripke S; Niesler B; Zucchelli M; Rivera NV; Schmidt PT; Pedersen NL; Magnusson P; Talley NJ; Holliday EG; Houghton L; Gazouli M; Karamanolis G; Rappold G; Burwinkel B; Surowy H; Rafter J; Assadi G; Li L; Papadaki E; Gambaccini D; Marchi S; Colucci R; Blandizzi C; Barbaro R; Karling P; Walter S; Ohlsson B; Tornblom H; Bresso F; Andreasson A; Dlugosz A; Simren M; Agreus L; Lindberg G; Boeckxstaens G; Bellini M; Stanghellini V; Barbara G; Daly MJ; Camilleri M; Wouters MM; D'Amato M
Gut; 2015 Nov; 64(11):1774-82. PubMed ID: 25248455
[TBL] [Abstract] [Full Text] [Related]
14. Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab -- a translational project in the neoadjuvant GeparQuinto trial.
Witzel I; Loibl S; von Minckwitz G; Eidtmann H; Fehm T; Khandan F; Schmatloch S; Hauschild M; Bischoff J; Fasching PA; Mau C; Schem C; Rack B; Meinhold-Heerlein I; Liedtke C; Karn T; Huober J; Zu Eulenburg C; Issa-Nummer Y; Untch M; Müller V
Br J Cancer; 2012 Sep; 107(6):956-60. PubMed ID: 22892393
[TBL] [Abstract] [Full Text] [Related]
15. Metaplastic breast carcinomas and their relationship with basal-like phenotype.
Cakir A; Gönül II; Uluoğlu O
Turk Patoloji Derg; 2012; 28(2):134-41. PubMed ID: 22627631
[TBL] [Abstract] [Full Text] [Related]
16. Urinary rubidium in breast cancers.
Su Y; Chen LJ; He JR; Yuan XJ; Cen YL; Su FX; Tang LY; Zhang AH; Chen WQ; Lin Y; Wang SM; Ren ZF
Clin Chim Acta; 2011 Nov; 412(23-24):2305-9. PubMed ID: 21910977
[TBL] [Abstract] [Full Text] [Related]
17. Menstruation during and after caloric restriction: the 1944-1945 Dutch famine.
Elias SG; van Noord PA; Peeters PH; den Tonkelaar I; Kaaks R; Grobbee DE
Fertil Steril; 2007 Oct; 88(4 Suppl):1101-7. PubMed ID: 17544416
[TBL] [Abstract] [Full Text] [Related]
18. Expression and localization of homeodomain proteins DLX4/hb9 in normal and malignant human breast tissues.
Neufing PJ; Kalionis B; Horsfall DJ; Ricciardelli C; Stahl J; Vivekanandan S; Raymond W; Tilley WD
Anticancer Res; 2003; 23(2B):1479-88. PubMed ID: 12820413
[TBL] [Abstract] [Full Text] [Related]
19. BRCA2 germline mutations in Japanese breast cancer families.
Inoue R; Ushijima T; Fukutomi T; Fukami A; Sugimura H; Inoue S; Okonogi H; Sugimura T; Matsumoto Y; Nagao M
Int J Cancer; 1997 Apr; 74(2):199-204. PubMed ID: 9133456
[TBL] [Abstract] [Full Text] [Related]
